Showing results (11-20 of 47) with videos related to
Sort By:
Pageof 5
The American Journal of Physiology|July 1, 1985
Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact plateletsL D Brace, D L Venton, G C Le BretonThe Journal of Pharmacology and Experimental Therapeutics|July 1, 1982
Thromboxane A2/prostaglandin H2 directly stimulates platelet shape change independent of secreted ADPL V Parise, D L Venton, G C Le BretonFEBS Letters|January 30, 1989
Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human plateletsP G Swann, D L Venton, G C Le BretonBioorganic & Medicinal Chemistry Letters|October 6, 1999
Combinatorial search of substituted beta-cyclodextrins for phosphatase-like activityJ Yu, Y Zhao, M J Holterman, et al.Journal of Medicinal Chemistry|July 1, 1979
Azaprostanoic acid derivatives. Inhibitors of arachidonic acid induced platelet aggregationD L Venton, S E Enke, G C Le BretonThrombosis Research|February 15, 1986
Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548)E J Kattelman, D L Venton, G C Le BretonThe Journal of Pharmacology and Experimental Therapeutics|January 1, 1984
Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interactionL V Parise, D L Venton, G C Le BretonThrombosis Research|December 15, 1982
Prostacyclin potentiates 13-azaprostanoic acid-induced platelet deaggregationL V Parise, D L Venton, G C Le BretonBiochimica Et Biophysica Acta|March 22, 1983
The thromboxane antagonist, 13-azaprostanoic acid, inhibits arachidonic acid-induced Ca2+ release from isolated platelet membrane vesiclesJ P Rybicki, D L Venton, G C Le BretonJournal of Medicinal Chemistry|January 1, 1975
Carbocyclic prostaglandin analogs. 1. Steroid carboxylic acidsD L Venton, R E Counsell, J H Sanner, et al.Pageof 5